Evidence map›Paper›PMID 38470719›Full record

ArticleNanomaterials (Basel, Switzerland)2024

Unveiling the MIL-53(Al) MOF: Tuning Photoluminescence and Structural Properties via Volatile Organic Compounds Interactions.

Tanzeel Ul Rehman, Simonpietro Agnello, Franco Mario Gelardi, Martina Maria Calvino, Giuseppe Lazzara, Gianpiero Buscarino, Marco Cannas

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Tanzeel Ul RehmanDipartimento di Fisica e Chimica-Emilio Segrè, Università degli Studi di Palermo, 90123 Palermo, Italy.ORCID 0009-0006-1024-2830
Simonpietro AgnelloDipartimento di Fisica e Chimica-Emilio Segrè, Università degli Studi di Palermo, 90123 Palermo, Italy.ORCID 0000-0002-0346-8333
Franco Mario GelardiDipartimento di Fisica e Chimica-Emilio Segrè, Università degli Studi di Palermo, 90123 Palermo, Italy.ORCID 0000-0002-9636-3054
Martina Maria CalvinoDipartimento di Fisica e Chimica-Emilio Segrè, Università degli Studi di Palermo, 90123 Palermo, Italy.
Giuseppe LazzaraDipartimento di Fisica e Chimica-Emilio Segrè, Università degli Studi di Palermo, 90123 Palermo, Italy.ORCID 0000-0003-1953-5817
Gianpiero BuscarinoDipartimento di Fisica e Chimica-Emilio Segrè, Università degli Studi di Palermo, 90123 Palermo, Italy.
Marco CannasDipartimento di Fisica e Chimica-Emilio Segrè, Università degli Studi di Palermo, 90123 Palermo, Italy.ORCID 0000-0001-8236-5043
University of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MIL-53(Al) is a metal-organic framework (MOF) with unique properties, including structural flexibility, thermal stability, and luminescence. Its ability to adsorb volatile organic compounds (VOCs) and water vapor makes it a promising platform for sensing applications. This study investigated the adsorption mechanism of MIL-53(Al) with different VOCs, including ketones, alcohols, aromatics, and water molecules, focusing on structural transformations due to pore size variation and photoluminescence properties. The reported results assess MIL-53(Al) selectivity towards different VOCs and provide insights into their fundamental properties and potential applications in sensing.

Indexed as

guest-adsorptionMetal-Organic FrameworksMIL-53(Al)photoluminescencestructural transitionsVOCs

Identifiers

PMID38470719
PMCPMC10935077
OpenAlexW4391967426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.